MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression
Related Experiment Video
Updated: Sep 29, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
1Department of Ophthalmology, Wuchang Eyegood Ophthalmic Hospital, Wuhan, China.
Abstract:
Retinoblastoma is a familial inherited embryonic neuroretinal malignancy with a low survival rate and poor prognosis. Our study aimed to evaluate the potential interaction between microRNA miR-657 and the peroxisome proliferator-activated receptor alpha (PPARA) in retinoblastoma. Expression of miR-657 and PPARA was analyzed in retinoblastoma tissues and cells using RT-qPCR. Cell proliferation, apoptosis, and migration were measured in retinoblastoma cell lines, and xenografting experiments were performed using nude mice. Our study showed that miR-657 expression was markedly increased, whereas that of PPARA was markedly decreased in retinoblastoma. Additionally, PPARA knockdown enhanced the development of retinoblastoma. miR-657 enhanced the retinoblastoma tumorigenesis by directly inhibiting PPARA expression, suggesting that PPARA targeting by miR-657 facilitates retinoblastoma development by enhancing cell growth. This study provides novel insights into the miR-657- and PPARA-mediated mechanisms underlying retinoblastoma progression and suggests that the interaction between miR-657 and PPARA may serve as an effective target for therapeutic intervention.
Insights
MicroRNA miR-657 is elevated in retinoblastoma, a rare eye cancer. It inhibits PPARA, promoting tumor growth and suggesting a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Retinoblastoma is a serious inherited eye cancer with poor outcomes.
- Understanding molecular mechanisms is crucial for developing new treatments.
Purpose of the Study:
- To investigate the relationship between microRNA miR-657 and peroxisome proliferator-activated receptor alpha (PPARA) in retinoblastoma.
- To explore their roles in retinoblastoma progression and potential as therapeutic targets.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) to measure miR-657 and PPARA expression in tumor tissues and cells.
- In vitro assays assessing cell proliferation, apoptosis, and migration in retinoblastoma cell lines.
- In vivo xenograft experiments using nude mice to evaluate tumor development.
Main Results:
- miR-657 expression was significantly higher, while PPARA expression was significantly lower in retinoblastoma.
- PPARA knockdown accelerated retinoblastoma development.
- miR-657 directly suppressed PPARA, enhancing retinoblastoma cell growth and tumorigenesis.
Conclusions:
- miR-657 promotes retinoblastoma progression by inhibiting PPARA.
- The miR-657-PPARA axis represents a potential therapeutic strategy for retinoblastoma.
Related Concept Videos
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Negative Regulator Molecules
Experimental RNAi

